Cargando…
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
TP53 aberrations constitute the highest risk subset of myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML). The International Consensus Classification questions the blast threshold between MDS and AML. In this study, we assess the distinction between MDS and AML for 76 patients with TP5...
Autores principales: | Patel, Shyam A., Cerny, Jan, Gerber, William K., Ramanathan, Muthalagu, Ediriwickrema, Asiri, Tanenbaum, Benjamin, Hutchinson, Lloyd, Meng, Xiuling, Flahive, Julie, Barton, Bruce, Gillis‐Smith, Andrew J., Suzuki, Sakiko, Khedr, Salwa, Selove, William, Higgins, Anne W., Miron, Patricia M., Simin, Karl, Woda, Bruce, Gerber, Jonathan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660125/ https://www.ncbi.nlm.nih.gov/pubmed/38024632 http://dx.doi.org/10.1002/jha2.791 |
Ejemplares similares
-
Predictors of vascular disease in myelodysplastic syndromes
por: Faber, Mark G., et al.
Publicado: (2020) -
Increased prescription rate of anti‐infective agents after diagnosis of myelodysplastic syndromes
por: Rozema, Johanne, et al.
Publicado: (2022) -
Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
por: Wang, Yu‐Hung, et al.
Publicado: (2022) -
Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2022) -
Increased body mass index is a risk factor for acute promyelocytic leukemia
por: Kashanian, Sarah M., et al.
Publicado: (2021)